Pharmaceutical growth hormone formulations
US5612315A · kind A · utility
22Cited by
8References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 1992 |
| Grant date | Mar 18, 1997 |
| Priority date | — |
| Expiry date | Jul 6, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/183
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Parenteral pharmaceutical formulations of human growth hormone, which are stabilized against aggregation, comprising biosynthetic human growth hormone, glycine, and mannitol. Methods of reducing aggregation of human growth hormone in parenteral formulations are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.